These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 395541)

  • 1. Clinical pharmacology of inhibitors of platelet aggregation.
    Fuccella LM
    Pharmacol Res Commun; 1979 Nov; 11(10):825-52. PubMed ID: 395541
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the platelet in coagulation and clinical thrombotic events.
    Porter JM; Goodnight SH
    Am J Surg; 1977 Aug; 134(2):231-5. PubMed ID: 889037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin in vascular pathology--therapeutic possibilities.
    Gryglewski RJ; Szczeklik A
    Ann Clin Res; 1984; 16(5-6):253-61. PubMed ID: 6398663
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits.
    Löbel P; Palmér M; Schrör K
    Prog Clin Biol Res; 1987; 242():265-70. PubMed ID: 3313414
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function inhibitors: their clinical use.
    Fuster V; Didisheim P
    Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease.
    Boss AH; Boysen G; Olseen JS
    Eur J Clin Invest; 1985 Dec; 15(6):412-4. PubMed ID: 3938412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
    Volkov VI; Ladnyĭ AI
    Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet and antiplatelet agents in strokes.
    Rodvien R; Mielke CH
    Stroke; 1978; 9(4):403-5. PubMed ID: 675751
    [No Abstract]   [Full Text] [Related]  

  • 15. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release.
    Leach CM; Thorburn GD
    Prostaglandins; 1980 Jul; 20(1):51-6. PubMed ID: 7403573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease.
    Svensson J; Samuelsson K
    Thromb Res; 1983 Aug; 31(3):499-505. PubMed ID: 20218005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.